Home Uncategorized

Uncategorized

Latest

atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference

atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase...

atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference

atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors

atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate...

atai Life Sciences Announces Dosing of First Patient in Part 2...

atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1...

atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial...

atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase...

atai Life Sciences Announces First Participant Dosed in Phase 1b Trial...

Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC)...

atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate...

atai Life Sciences Appoints Anne Johnson as Chief Financial Officer

atai Life Sciences Announces Completion of Phase 1 Study of VLS-01...

12 3...13 Page 1 of 13

Statement Regarding The Church of the Sacred Synthesis

Breaking: atai Moves to Acquire Beckley, If Phase 2b 5-MeO-DMT Data...

Pα+ Psychedelic Bulletin #199: Lykos Takeover Nears Completion; Fewer than 100...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.